Skip to content

DW-1C DWFA-1CRecalls & reported problems

DongWon Medical CO.,LTD. · Class 2 · Implant

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08800050100000), received between Dec 22, 2025 and Dec 22, 2025 — classified as 1 injury.

The most frequently reported specific device problem is “Patient Device Interaction Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 1 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Patient Device Interaction Problem1

Patient problems

  • Erythema1
  • Granuloma1
  • Nodule1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 22, 2025Patient Device Interaction Problem; Patient Device Interaction Problem

    ON (B)(6) 2025, THE HEALTHCARE PROVIDER (HCP) REPORTED THAT THE PATIENT DEVELOPED REDNESS WITH STREAKING AND SWELLING ALONG THE LEFT CHEEK APPROXIMATELY 10 DAYS POST-TREATMENT, FOLLOWING ACCIDENTAL CONTACT WITH THE TREATED AREA. THE PATIENT SUBSEQUENTLY DEVELOPED AN OPEN WOUND, AND DERMATOLOGY EXPRESSED CONCERN REGARDING ACTIVE BLEEDING. THE PATIENT HAS BEEN EVALUATED BY A NURSE PRACTITIONER (NP) AND A MEDICAL DOCTOR (MD) AND IS CURRENTLY ON A SECOND COURSE OF ANTIBIOTICS. THE HCP REQUESTED CONSULTATION WITH THE MEDICAL DIRECTOR FOR FURTHER CLINICAL GUIDANCE. ON DECEMBER 20, 2025, THE MEDICAL DIRECTOR SPOKE WITH THE HCP TO DISCUSS THE CASE AND PROVIDE GUIDANCE. PATIENT OUTCOME REMAINS PENDING AT THE TIME OF THIS REPORT. UPDATE WILL BE PROVIDED IF AND WHEN IT BECOMES AVAILABLE. UPDATE: ON JANUARY 5TH, 2026, A FOLLOW UP EMAIL WAS SENT TO THE SALES REPRESENTATIVE TO CHECK ON THE STATUS OF THE PATIENT. NO RESPONSE WAS RECEIVED. ON JANUARY 13TH, 2026, ANOTHER FOLLOW UP EMAIL WAS SENT TO CHECK ON THE STATUS OF THE PATIENT. THE SALES REPRESENTATIVE PROVIDED AN UPDATE FROM A TEXT EXCHANGE IN WHICH THE HCP REPORTED THAT THE PATIENT WAS SEEN BY DERMATOLOGIST AND DIAGNOSED WITH A GRANULOMA. T

    Patient problems: Erythema; Granuloma; Nodule

    MAUDE report 23865697 ↗

Other Suture, Surgical, Absorbable, Polydioxanone devices

All Suture, Surgical, Absorbable, Polydioxanone devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.